Ionis Pharmaceuticals Newsroom

Catalyst Watch: FOMC Meeting, Govt. Funding Drama, Earnings for Micron, Nike, and FedEx

Seeking AlphaDec 13 15:00 ET

Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com

BusinesswireDec 11 12:41 ET

How Much Upside Is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91%

Zacks Dec 11 09:05 ET

Oppenheimer Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $75

Moomoo NewsDec 10 08:34 ET · Ratings

Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound?

Yahoo FinanceDec 6 11:31 ET

Ionis Pharmaceuticals Management to Meet With Oppenheimer

TipRanksDec 5 16:53 ET

Strong Week for Ionis Pharmaceuticals (NASDAQ:IONS) Shareholders Doesn't Alleviate Pain of Five-year Loss

Simply Wall StDec 5 14:19 ET

TD Cowen Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $59

Moomoo NewsDec 5 12:35 ET · Ratings

Flamingo Therapeutics Announces Poster Presentation on AML Phase 1 IIT Study at ASH 2024

PR NewswireDec 4 08:00 ET

Theratechnologies Announced It Has Entered Into An Agreement With Ionis Pharmaceuticals To License Two Investigational RNA-targeted Medicines Developed By Ionis

BenzingaDec 4 07:40 ET

Raymond James Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $61

Moomoo NewsDec 2 09:31 ET · Ratings

Express News | Ionis Pharmaceuticals Inc : Raymond James Adds Stock to Its Analyst Current Favorites List

ReutersDec 2 07:43 ET

J.P. Morgan Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $51

Moomoo NewsNov 28 07:31 ET · Ratings

Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and GoodRx Holdings (GDRX)

TipRanksNov 28 07:10 ET · Ratings

Ionis Pharmaceuticals (IONS) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Nov 27 11:15 ET

Praxis Precision Medicines to Showcase Updates From Largest Epilepsy Pipeline of Precision Epilepsy Programs at the 2024 American Epilepsy Society Annual Meeting

GlobeNewswireNov 26 08:00 ET

Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby

Seeking AlphaNov 23 08:26 ET

Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now

Yahoo FinanceNov 19 19:08 ET

Here's Why Ionis Pharmaceuticals (IONS) Is Poised for a Turnaround After Losing -13.46% in 4 Weeks

Zacks Nov 18 08:50 ET

Express News | Shares of Pharmaceutical and Healthcare Stocks Are Trading Lower. The Sector Has Been Under Pressure After President-elect Trump Nominated Robert F. Kennedy Jr. to Lead the HHS

BenzingaNov 15 15:21 ET